Slimcarb assists in the treatment of obesity by inhibiting salivary , pancreatic and intestinal a-glycosidase enzyme activity, thereby promoting a delayed absorption of carbohydrates and glucose . In addition, Slimcarb has an inhibitory action on pancreatic lipase – an enzyme responsible for digesting fat. Reduces carbohydrate , glucose and fat absorption. Slimcarb blocks the activity of salvatory & intestinal enzymes, thereby inhibiting the absorption of carbohydrates and glucose. This anti-nutrient effect of the phytoactive on a a-amylase and a-glycosidase assists in the management of obesity. Slimcarb similarly inhibits pancreatic lipase , an enzyme responsible for breaking down 50 – 70% of the total fats we ingest. The result is a direction prevention of weight gain.